Alpha Particle Emitter Radiolabeled Antibody for Metastatic Cancer: What Can We Learn from Heavy Ion Beam Radiobiology?

Alpha-particle emitter labeled monoclonal antibodies are being actively developed for treatment of metastatic cancer due to the high linear energy transfer (LET) and the resulting greater biological efficacy of alpha-emitters. Our knowledge of high LET particle radiobiology derives primarily from ac...

Full description

Bibliographic Details
Main Authors: Hong Song, Srinivasan Senthamizhchelvan, Robert F. Hobbs, George Sgouros
Format: Article
Language:English
Published: MDPI AG 2012-06-01
Series:Antibodies
Subjects:
Online Access:http://www.mdpi.com/2073-4468/1/2/124